Extendicare Revenue vs. Market Capitalization
| EXE Stock | CAD 10.62 0.04 0.38% |
Total Revenue | First Reported 2003-03-31 | Previous Quarter 348.5 M | Current Value 359.1 M | Quarterly Volatility 166.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.13 | 0.0908 |
|
| |||||
| Operating Profit Margin | 0.077 | 0.0857 |
|
|
For Extendicare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Extendicare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Extendicare utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Extendicare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Extendicare over time as well as its relative position and ranking within its peers.
Extendicare |
Extendicare Market Capitalization vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. Extendicare is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in market capitalization category among its peers creating about 0.68 of Market Capitalization per Revenue. The ratio of Revenue to Market Capitalization for Extendicare is roughly 1.47 . At this time, Extendicare's Total Revenue is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Extendicare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Extendicare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Extendicare Revenue vs. Competition
Extendicare is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 7.68 Billion. Extendicare retains roughly 1.3 Billion in revenue claiming about 17% of equities under Health Care industry.
Extendicare Market Capitalization vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Extendicare |
| = | 1.3 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Extendicare |
| = | 886.42 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Extendicare Market Capitalization vs Competition
Extendicare is one of the top stocks in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 12.11 Billion. Extendicare holds roughly 886.42 Million in market capitalization claiming about 7% of equities under Health Care industry.
Extendicare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Extendicare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Extendicare will eventually generate negative long term returns. The profitability progress is the general direction of Extendicare's change in net profit over the period of time. It can combine multiple indicators of Extendicare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 957 K | 1 M | |
| Operating Income | 111.8 M | 94.2 M | |
| Income Before Tax | 44.8 M | 31.2 M | |
| Total Other Income Expense Net | -67 M | -70.3 M | |
| Net Income | 34 M | 31.8 M | |
| Income Tax Expense | 10.8 M | 10.5 M | |
| Net Income From Continuing Ops | 34 M | 21.4 M | |
| Net Income Applicable To Common Shares | 62.6 M | 36.1 M | |
| Interest Income | 6.2 M | 5.9 M | |
| Net Interest Income | -15.5 M | -16.3 M | |
| Change To Netincome | -51.3 M | -48.8 M | |
| Net Income Per Share | 0.40 | 0.25 | |
| Income Quality | 0.69 | 0.65 | |
| Net Income Per E B T | 0.76 | 0.74 |
Extendicare Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Extendicare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Extendicare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Extendicare's important profitability drivers and their relationship over time.
Use Extendicare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Extendicare Pair Trading
Extendicare Pair Trading Analysis
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Extendicare position
In addition to having Extendicare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Extendicare Stock
To fully project Extendicare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Extendicare at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Extendicare's income statement, its balance sheet, and the statement of cash flows.